PDE5A and pulmonary arterial hypertension: In the lung, PDE5 inhibitors act as vasodilators, increasing blood supply, antagonizing the vasoconstriction of smooth muscle, and decreasing pulmonary arterial resistance, thus treating pulmonary hypertension (for comprehensive review see [172–174]).